201 related articles for article (PubMed ID: 16478820)
1. Second primary cancers in thyroid cancer patients: a multinational record linkage study.
Sandeep TC; Strachan MW; Reynolds RM; Brewster DH; Scélo G; Pukkala E; Hemminki K; Anderson A; Tracey E; Friis S; McBride ML; Kee-Seng C; Pompe-Kirn V; Kliewer EV; Tonita JM; Jonasson JG; Martos C; Boffetta P; Brennan P
J Clin Endocrinol Metab; 2006 May; 91(5):1819-25. PubMed ID: 16478820
[TBL] [Abstract][Full Text] [Related]
2. Risk of second primary cancer among esophageal cancer patients: a pooled analysis of 13 cancer registries.
Chuang SC; Hashibe M; Scelo G; Brewster DH; Pukkala E; Friis S; Tracey E; Weiderpass E; Hemminki K; Tamaro S; Chia KS; Pompe-Kirn V; Kliewer EV; Tonita JM; Martos C; Jonasson JG; Dresler CM; Boffetta P; Brennan P
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1543-9. PubMed ID: 18559572
[TBL] [Abstract][Full Text] [Related]
3. Elevated risks of subsequent primary malignancies in patients with thyroid cancer: a nationwide, population-based study in Korea.
Cho YY; Lim J; Oh CM; Ryu J; Jung KW; Chung JH; Won YJ; Kim SW
Cancer; 2015 Jan; 121(2):259-68. PubMed ID: 25223713
[TBL] [Abstract][Full Text] [Related]
4. Thyroid cancer and multiple primary tumors in the SEER cancer registries.
Ronckers CM; McCarron P; Ron E
Int J Cancer; 2005 Nov; 117(2):281-8. PubMed ID: 15880372
[TBL] [Abstract][Full Text] [Related]
5. Risk of second primary malignancies in women with papillary thyroid cancer.
Canchola AJ; Horn-Ross PL; Purdie DM
Am J Epidemiol; 2006 Mar; 163(6):521-7. PubMed ID: 16421240
[TBL] [Abstract][Full Text] [Related]
6. Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries.
Olsen JH; Möller T; Anderson H; Langmark F; Sankila R; Tryggvadóttír L; Winther JF; Rechnitzer C; Jonmundsson G; Christensen J; Garwicz S
J Natl Cancer Inst; 2009 Jun; 101(11):806-13. PubMed ID: 19470947
[TBL] [Abstract][Full Text] [Related]
7. Second malignancies among survivors of germ-cell testicular cancer: a pooled analysis between 13 cancer registries.
Richiardi L; Scélo G; Boffetta P; Hemminki K; Pukkala E; Olsen JH; Weiderpass E; Tracey E; Brewster DH; McBride ML; Kliewer EV; Tonita JM; Pompe-Kirn V; Kee-Seng C; Jonasson JG; Martos C; Brennan P
Int J Cancer; 2007 Feb; 120(3):623-31. PubMed ID: 17096341
[TBL] [Abstract][Full Text] [Related]
8. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
9. Second primary cancers in patients with nasopharyngeal carcinoma: a pooled analysis of 13 cancer registries.
Scélo G; Boffetta P; Corbex M; Chia KS; Hemminki K; Friis S; Pukkala E; Weiderpass E; McBride ML; Tracey E; Brewster DH; Pompe-Kirn V; Kliewer EV; Tonita JM; Martos C; Jonasson JG; Brennan P
Cancer Causes Control; 2007 Apr; 18(3):269-78. PubMed ID: 17237987
[TBL] [Abstract][Full Text] [Related]
10. Second neoplasms after invasive and borderline ovarian cancer.
Levi F; Randimbison L; Blanc-Moya R; La Vecchia C
Eur J Cancer Prev; 2009 Jun; 18(3):216-9. PubMed ID: 19491608
[TBL] [Abstract][Full Text] [Related]
11. Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation.
Tuohimaa P; Pukkala E; Scélo G; Olsen JH; Brewster DH; Hemminki K; Tracey E; Weiderpass E; Kliewer EV; Pompe-Kirn V; McBride ML; Martos C; Chia KS; Tonita JM; Jonasson JG; Boffetta P; Brennan P
Eur J Cancer; 2007 Jul; 43(11):1701-12. PubMed ID: 17540555
[TBL] [Abstract][Full Text] [Related]
12. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
[TBL] [Abstract][Full Text] [Related]
13. Second primary cancers after cancers of the colon and rectum in New South Wales, Australia, 1972-1991.
McCredie M; Macfarlane GJ; Bell J; Coates M
Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):155-60. PubMed ID: 9138657
[TBL] [Abstract][Full Text] [Related]
14. Trends of Second Primary Malignancy in Patients with Thyroid Cancer: A Population-Based Cohort Study in Israel.
Izkhakov E; Barchana M; Liphshitz I; Silverman BG; Stern N; Keinan-Boker L
Thyroid; 2017 Jun; 27(6):793-801. PubMed ID: 28338430
[TBL] [Abstract][Full Text] [Related]
15. Occupation and cancer - follow-up of 15 million people in five Nordic countries.
Pukkala E; Martinsen JI; Lynge E; Gunnarsdottir HK; Sparén P; Tryggvadottir L; Weiderpass E; Kjaerheim K
Acta Oncol; 2009; 48(5):646-790. PubMed ID: 19925375
[TBL] [Abstract][Full Text] [Related]
16. Risk of second primary cancer among patients with head and neck cancers: A pooled analysis of 13 cancer registries.
Chuang SC; Scelo G; Tonita JM; Tamaro S; Jonasson JG; Kliewer EV; Hemminki K; Weiderpass E; Pukkala E; Tracey E; Friis S; Pompe-Kirn V; Brewster DH; Martos C; Chia KS; Boffetta P; Brennan P; Hashibe M
Int J Cancer; 2008 Nov; 123(10):2390-6. PubMed ID: 18729183
[TBL] [Abstract][Full Text] [Related]
17. The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer.
Brown AP; Chen J; Hitchcock YJ; Szabo A; Shrieve DC; Tward JD
J Clin Endocrinol Metab; 2008 Feb; 93(2):504-15. PubMed ID: 18029468
[TBL] [Abstract][Full Text] [Related]
18. Risk of second cancer among women with breast cancer.
Mellemkjaer L; Friis S; Olsen JH; Scélo G; Hemminki K; Tracey E; Andersen A; Brewster DH; Pukkala E; McBride ML; Kliewer EV; Tonita JM; Kee-Seng C; Pompe-Kirn V; Martos C; Jonasson JG; Boffetta P; Brennan P
Int J Cancer; 2006 May; 118(9):2285-92. PubMed ID: 16342146
[TBL] [Abstract][Full Text] [Related]
19. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study.
Spanogle JP; Clarke CA; Aroner S; Swetter SM
J Am Acad Dermatol; 2010 May; 62(5):757-67. PubMed ID: 20223559
[TBL] [Abstract][Full Text] [Related]
20. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]